Outlook Therapeutics (OTLK) Long-Term Debt Repayments (2015 - 2025)
Outlook Therapeutics (OTLK) recorded Long-Term Debt Repayments of $2.33 million in fiscal Q4 2025 (quarter ended Sep 30, 2025), up 156.4% from the prior quarter.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Long-Term Debt Repayments (2015 - 2025) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Outlook Therapeutics reported Long-Term Debt Repayments of $36.14 million.
- Annual Long-Term Debt Repayments has a five-year compound annual growth rate of 178.7% (FY2020 to FY2025).
- Across earlier fiscal years, Long-Term Debt Repayments came in at $4,267 in FY2024 (-100.0%), $10.22 million in FY2023 (-16.9%), $12.29 million in FY2022 (+240.3%) and $3.61 million in FY2021.
- The fiscal Q4 2025 figure is the highest quarterly Long-Term Debt Repayments since fiscal Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Outlook Therapeutics | 77.51 Mn | 41.76 Mn | -8,265.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 906,977.00 |
| Mar 31, 2024 | 1,084.00 |
| Dec 31, 2023 | 3,183.00 |
| Sep 30, 2023 | 3,082.00 |
| Jun 30, 2023 | 2,983.00 |
| Mar 31, 2023 | 2,889.00 |
| Dec 31, 2022 | 10.22 Mn |
| Sep 30, 2022 | 5,685.00 |
| Jun 30, 2022 | 11.60 Mn |
| Mar 31, 2022 | 308,327.00 |
| Dec 31, 2021 | 408,668.00 |
| Sep 30, 2021 | 19,722.00 |
| Jun 30, 2021 | 19,232.00 |
| Mar 31, 2021 | 18,755.00 |
| Dec 31, 2020 | 3.63 Mn |
| Sep 30, 2020 | 30,685.00 |
| Jun 30, 2020 | 30,420.00 |
| Mar 31, 2020 | 135,600.00 |
| Dec 31, 2019 | 66,571.00 |
API Access
Outlook Therapeutics Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();